- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Locations
-
- The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
- Anhui Provincial Cancer Hospital Hefei, Anhui, China
- Peking University First Hospital Beijing, Beijing Municipality, China
- Beijing Friendship Hospital,Capital Medical University Beijing, Beijing Municipality, China
Clinical trial condition
Metastatic Pancreatic Ductal Adenocarcinoma
Explore clinical trials studying Metastatic Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.
44 public trials
17 recruiting studies
Metastatic Pancreatic Ductal Adenocarcinoma trial results
NCT06904378
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT06648434
- Conditions
- Cancer of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Recruiting
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
NCT07089940
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Recruiting
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
NCT04150042
- Conditions
- Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation, +35 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT06600906
- Conditions
- Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT05472259
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Locations
-
- UZ Antwerpen Antwerp, Belgium
- ULB Erasme Brussels, Brussels Capital, Belgium
- Cliniques Universitaires Saint-Luc UCL Brussels, Brussels Capital, Belgium
- CHC MontLégia Liège, Belgium
Not yet recruiting
Rimegepant Combined With AG Chemotherapy As First-Line Treatment For Metastatic Pancreatic Ductal Adenocarcinoma
NCT07475234
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Locations
-
Not specified
Not yet recruiting
Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
NCT07445295
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not yet recruiting
Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma
NCT06981806
- Conditions
- Metastatic Pancreatic Ductal Adenocarcinoma
- Locations
-
- Cedars-Sinai Cancer at SOCC Los Angeles, California, United States